PT Ikapharmindo Putramas Tbk (IDX:IKPM)
Indonesia · Delayed Price · Currency is IDR 194.00
0.00 (0.00%)
Last updated: Sep 2, 2026, 11:51 AM WIB
IDX:IKPM Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 400,249 | 363,565 | 412,069 | 441,137 | 398,735 | 380,917 |
Revenue Growth | 2.03% | -11.77% | -6.59% | 10.63% | 4.68% | -46.78% |
Gross Profit Gross Profit Growth | 169,568 | 147,472 | 185,528 | 188,968 | 180,788 | 177,272 |
Operating Income Operating Income Growth | -14,836 | -24,485 | 17,514 | 31,780 | 33,226 | 25,005 |
Net Income Net Income Growth | -16,755 | -28,785 | 5,015 | 15,338 | 16,578 | 8,125 |
Earnings Per Share EPS Growth | -9.94 | -17.09 | 2.98 | 17.08 | 16.58 | 8.13 |
EPS Growth | - | - | -82.57% | 3.05% | 104.02% | 75.56% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmacy Pharmacy Growth | 226,933 | 211,653 | 197,085 | 198,996 | 163,375 | 146,431 |
Contract Manufacturing Contract Manufacturing Growth | 515.8 | 498.89 | 510.57 | 551.74 | 563.52 | 439.77 |
Non-Pharma Non-Pharma Growth | 172,800 | 151,413 | 214,474 | 241,589 | 234,796 | 234,046 |
Total Total Growth | 400,249 | 363,565 | 412,069 | 441,137 | 398,735 | 380,917 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 41,889 | 47,018 | 23,830 | 44,294 | 10,883 | 14,309 |
Total Debt Total Debt Growth | 170,623 | 170,923 | 170,989 | 149,400 | 144,234 | 138,773 |
Net Cash (Debt) Net Cash Growth | -128,733 | -123,904 | -147,159 | -105,107 | -133,351 | -124,465 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -76.38 | -73.55 | -87.35 | -117.07 | -133.35 | -124.46 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 27,816 | 28,569 | -35,270 | 20,350 | -4,057 | 78,463 |
Capital Expenditures CapEx Growth | -3,033 | -4,863 | -2,292 | -44,093 | -2,990 | -2,067 |
Free Cash Flow Free Cash Flow Growth | 24,783 | 23,705 | -37,562 | -23,743 | -7,047 | 76,396 |
Free Cash Flow Growth | - | - | - | - | - | 967.08% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 42.37% | 40.56% | 45.02% | 42.84% | 45.34% | 46.54% |
Operating Margin | -3.71% | -6.73% | 4.25% | 7.20% | 8.33% | 6.56% |
Pretax Margin | -5.86% | -9.76% | 1.95% | 4.71% | 5.70% | 3.18% |
Profit Margin | -4.19% | -7.92% | 1.22% | 3.48% | 4.16% | 2.13% |
FCF Margin | 6.19% | 6.52% | -9.12% | -5.38% | -1.77% | 20.06% |
| Fiscal Year | FY 2023 |
|---|---|
| Period Ending | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 2.250 |
Dividend Per Share Growth | - |
Dividend Yield | 1.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 81.97 | 22.19 | - | - |
P/FCF Ratio | 13.19 | 15.92 | - | - | - | - |
PS Ratio | 0.82 | 1.04 | 1.00 | 0.77 | - | - |